NI Medical is a biotechnology company and a leading developer and manufacturer of whole body bioimpedance systems, the Non Invasive Cardiac System (NICaS) and the Hemodynamic Navigator. Its goal is to provide non-invasive solutions to the various challenges in the cardiovascular field. These range from Hypertension, Chronic heart failure, Hemodialysis, ICU/ICCU, Neonatal, Obstetrics & Gynecology, and treatment of infectious diseases. The NI Medical NICaS System provides a much-needed solution for non-invasive hemodynamic and fluid management in both inpatient and outpatient settings. NI Medicals products have been certified worldwide with U.S. FDA 510(k), European CE mark, Canadian MDL, Japanese PMDA (Shonin), and Israeli AMAR approvals.